Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011

Ann Rheum Dis. 2012 Apr:71 Suppl 2:i2-45. doi: 10.1136/annrheumdis-2011-201036.
No abstract available

Publication types

  • Consensus Development Conference

MeSH terms

  • Abatacept
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy
  • Evidence-Based Medicine / methods
  • Humans
  • Immunoconjugates / therapeutic use
  • Interleukin 1 Receptor Antagonist Protein / therapeutic use
  • Rheumatic Diseases / drug therapy*
  • Rituximab
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • Immunoconjugates
  • Interleukin 1 Receptor Antagonist Protein
  • Tumor Necrosis Factor-alpha
  • Rituximab
  • Abatacept